# Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm

> **NCT04988932** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 7 (actual)

## Conditions studied

- SAH
- Inhaled Nitric Oxide
- Cerebral Ischemia
- Vasospasm

## Interventions

- **DRUG:** Inhaled nitric oxide

## Key facts

- **NCT ID:** NCT04988932
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-31
- **Primary completion:** 2019-07-28
- **Final completion:** 2020-03-20
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04988932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04988932, "Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04988932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*